Capital Rx, the enterprise health technology company and benefit administrator, today announced a $400 million investment, including a $252 million Series F funding round along with additional investments into the Company's securities, scheduled to close in early October, led by Wellington Management and General Catalyst, with participation from Generation Investment Management, Growth Equity at Goldman Sachs Alternatives, 9Yards Capital, B Capital, Edison Partners, Prime Health Investments, and Transformation Capital, among others. Concurrent with the investment, the Company is rebranding as Judi Health™ to better reflect its roots and broadened capabilities as a full-service health benefits technology company helping employers design and manage health benefit programs that meet their unique needs.

Capital Rx is a health technology company that is leading the transformation of the pharmacy benefits industry. Capital Rx's enterprise pharmacy platform, JUDI™, digitally links providers, patients, pharmacies, and plans to achieve the highest standard of clinical care. By establishing a competitive marketplace through its Clearinghouse Model™, Capital Rx unlocks the pharmacy supply chain to ensure patients receive seamless access to medication at the lowest price.